OCGN Ocugen new Covid-19 Vaccine and Price Target
OCGN Ocugen partnered with Bharat Biotech for Covaxin, the first COVID vaccine developed in India to receive emergency authorization.
With the COVID significant rise in cases, hospitalizations and deaths over the last two weeks, vaccines producers are rising once again.
My short term Price Target is 10.30usd
With the COVID significant rise in cases, hospitalizations and deaths over the last two weeks, vaccines producers are rising once again.
My short term Price Target is 10.30usd
Private SIGNALS patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。